Skip to main content
Sign In
 

Reuben M. Cherniack, M.D.

Professor of Medicine


 



 

  Reuben M. Cherniack, M.D. 
  Professor of Medicine

 

  University of Colorado Denver

  Pulmonary Sciences & Critical Care Medicine/P>

  Phone: 303-724-0000

 
  cherniackr@njc.org  

 

Education & Training

ROFESSIONAL EXPERIENCE
1951-1952
Fellow in Medicine, Presbyterian Hospital, Columbia University, New York
1952-1953
Lecturer, Department of Physiology and Medical Research, University of Manitoba
1953-1954
Fellow in Medicine, Johns Hopkins University, Baltimore
1954
Assistant Professor, Department of Physiology and Medical and Research and
Lecturer, Department of Medicine, University of Manitoba
1958
Assistant Professor, Department of Medicine, University of Manitoba
1964
Associate Professor, Department of Medicine, University of Manitoba
1966
Professor of Medicine, Department of Medicine, University of Manitoba
1967
Medical Director, D.A. Stewart Centre for the Study and Treatment of Respiratory Disease and
Physician-in-Chief, D.A. Stewart Centre for the Study and Treatment of Respiratory Disease
1974-1978
Chairman, Department of Medicine, University of Manitoba
Physician-in-Chief, Department of Medicine, Health Sciences Centre
1978-1984
Chairman, Department of Medicine, National Jewish Medical and Research Center, Denver
Professor and Vice Chairman, Department of Medicine, School of Medicine, University of Colorado Denver, Denver
1984-1992
Director, Pulmonary Physiology Unit, National Jewish Medical and Research Center, Denver
Professor of Medicine, Department of Medicine, University of Colorado Denver, Denver
1992-present
Senior Faculty Member, National Jewish Medical and Research Center, Denver


HONORS

1955 Fellow, Royal College of Physicians (Canada)
1961 Fellow, American College of Physicians
1969 Charter Member, Johns Hopkins Society of Scholars
1970 Fellow, American College of Chest Physicians
1976 Honorary Fellow, Royal College of Physicians, London, England
1977 Queen Elizabeth Medal for Achievement, Canada
1977 Honorary Life Membership Canadian Thoracic Society
1983 Honorary Degree, Doctor of Science, University of Manitoba
1986 James Waring Award for Scientific Excellence, American Lung Association of Colorado
1987 Canadian Society for Clinical Investigation, Distinguished Service Award
1996 Distinguished Professor of Medicine, University of Colorado
1998 ALA/ATS Trudeau Medal


SELECTED PUBLICATIONS 
Childhood Asthma Management Program Research Group. Recruitment of Participants in the Childhood Asthma Management Program (CAMP). Childhood Asthma Management Program Research Group J. Asthma 36(3) 217-237, 1999


Cherniack RM. Tonascia J. and the Childhood Asthma Management Program Research Group: The Childhood Asthma Management Program (CAMP): Design, Rational, and Methods. Controlled Clinical Trials 20:91-120, 1999


Martin,R.J. Pak,J. Kunselman S.J. Cherniack, R. M. and ACRN. Assessment of the AirWatch Lung Function Monitoring System. J. Allergy Clin Immunol 103:535-6,1999


Zeiger RS, Dawson, C. Weiss S, Cherniack RM for the Childhood Asthma Management Program (CAMP) Research Group: Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP) J. Allergy Clin Immunol 103:376-87, 1999


The Emphysema Treatment Trial Research Group Rationale and Design of the National Emphysema Treatment Trial: A prospective Randomized Trial of Lung Volume Reduction Surgery.Chest 116:1750-1761,1999


Nelson,HS, Szefler,SJ Jacobs,J, Huss,K Shapiro,G Sternberg,AL Cherniack RM and the Childhood Asthma Management Program Research Group: Relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the Childhood Asthma Management Program J. Allergy Clin Immunol 104: 775-785, 1999


Childhood Asthma Management Program Research Group. Design and implementation of a patient education center for the Childhood Asthma Management Program (CAMP) Ann Allergy Asthma Immunol 81:571-579,1998


Annett R, Aylward F, Lapidus J, Bender B, DuHamel T, Cherniack RM for the Childhood Asthma Management Program Research Group: Neurocognitive functioning in children with mild and moderate asthma in the Childhood Asthma Management Program J. Allergy Clin Immunol 105:717-724, 2000
Israel E, Drazen JM,Liggett SB, Boushey H, Cherniack, RM, Chinchilli VM, Cooper DM, Fahy JV, Fish JE, Ford JG, Kraft M, Kunsekman S, Lazarus SC, LemanskE RF Jr, Martin RJ, McLean DE, Peters SP, Silverman EK, Sorkness CA, Szefler , Weiss ST, and Yandava CN. : The Effect of Polymorphisms of the b-2 Adrenergic Receptor on the Response to Regular Use of Albuterol in Asthma. Am J Respir Crit Care Med 162:75-80, 2000
Weiss ST, Van Natta ML, and Zeiger RS, Cherniack RM for the the Childhood Asthma Management Program Research Group : Relationship between Increased Airway Responsiveness and Asthma severity in the the Childhood Asthma Management Program. Am J Respir Crit Care Med 162:50-56, 2000


Bender B, Annett R. Bartelson B, DuHamel T, Rand C, Strunk, R, Cherniack RM for the Childhood Asthma Management Program Research Group~ Relationship between disease and psycbological adaptation in children in the ChildhoodAsthma Manapement Proeram and their families. Arch Pediatr Adolesc Med,154:706-713, 2000


Vourlekis, J S., Brown, KK.., Cool, CD, Cherniack, RM, King, TE. Jr., Schwarz, MI.Acute Interstitial Pneumonitis: Initial Presentation and Subsequent Course Medicine, 79:369-78, 2000


CAMP Research Group, Long term effects of Budesonide or Nedocromil in Chilren with Asthma, New Engl J Med 343:1054-1063, 2000


Weiss ST, VanNatta M. Zeiger R, Cherniack RM for the Childhood Asthma Management Program Research Group: Relationship between increased airwav responsiveness and asthma severity among children in the Childhood Asthma Management Program (CAMP) Am J Resp Crit Care Med 162:50-56, 2000


Israel E,,Drazen JM,Boushey HA,Cooper DM,Ford JG Kunselman S, Lemanske RF Jr,Liggett SB, Martin RJ Peters SP, Cherniack RM and the National Heart Lung and Blood Institute’s Asthma Clinical Research Network. The Effect of Polymorphisms of the b-Adrenergic Receptor on the Response to Regular Use of Albuterol in Asthma Am J Resp Crit Care Med 162:75-80, 2000


Fahy,JV Boushey,HA, Lazarus SC, Mauger EA, Cherniack RM, Chinchilli,VM Drazen, JM, Ford, JG Fish, JE, Israel,E, Kraft, M. Lemanske, RF, Martin, RJ, McLean,D,Peters,SP, Sorkness, C, Szefler SJ and the Asthma Clinical Research Network, NHLBI.:Safety and Reproducibility of Sputum Induction In Subjects with Moderate to Severe Asthma. Am J Resp Crit Care Med 163:1470-1475, 2001


Lazarus SC., Boushey, HA., Fahy, JV, Chinchilli, VM., Lemanske, RF., Sorkness,CAKraft, M, Fish, JE., Peters, SP.,Martin, RJ., Israel, E., Ford, JG., Cherniack RM and the Asthma Clinical Research Network NHLBI. Long Acting Beta?Agonist Monotherapy vs Continued Therapywith Inhaled Corticosteroids in Patients with Persistent Asthma: JAMA 285:2583-93, 2001


Lemanske, RF Jr., Sorkness, CA, Mauger EA, Lazarus, SC, Boushey HA, Fahy JV, Chinchilli,VE, Drazen,JE, Fish,JE. Ford, JG. Martin JM. Peters, SP, Cherniack RM and the Asthma Clinical Research Network NHLBI. Inhaled Corticosteroid Reduction and Elimination in Patients With Persistent Asthma receiving Salmeterol JAMA 285:2594-2603, 2001


Leone, FT, Mauger, EA Peters SP, Chinchilli VM, Fish JE, Boushey HA, Cherniack, RM, DrazenHM, Fahy JV, Ford J Israel E,Lazerus SÇ, Lemanske RF, Martin RJ McGeady SJ, Sorkness C Szefler SJ and the Asthma Clinical Research Network.NHLBI The utility of peak flow, symptom scores, and beta-agonist use as outcome measures in asthma clinical research. Chest 119: 1027-1033; 2001


Weiss ST, Horner A,Shapiro G, Sternberg A, Cherniack RM and the Childhood Asthma Management Program (CAMP research Group: The prevalence of environmental exposure to perceived asthma triggers in children with mild to moderate Asthma: Data from the Childhood Asthma Management Program (CAMP) J. Allergy and Clin Immunol1 07 : 634-640;2001 salmeterol. J.A.M.A. 2001;285:2594-2603.